phenyltoloxamine citrate 1.5 MG/ML

RxCUI: 1308441
RxNorm name: phenyltoloxamine citrate 1.5 MG/ML
Term type: SCDC
Status: Active
Updated: 2026-08-02 18:43:31

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 102012
Active start: 102012
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
	1.5 MG / 1 ML	phenyltoloxamine

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
phenyltoloxamine	33408

Source Vocabulary Codes#

Code type, Value, Category table
Code type	Value	Category
RXNAV_STR	phenyltoloxamine citrate 1.5 MG/ML	NAMES
RxNorm Name	phenyltoloxamine citrate 1.5 MG/ML	NAMES
TTY	SCDC	ATTRIBUTES
RxCUI	1308441	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
MEDRT	D001559	Benzhydryl Compounds	CHEM	has_ingredient	phenyltoloxamine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenyltoloxamine citrate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	phenyltoloxamine
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	phenyltoloxamine citrate
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	phenyltoloxamine
MEDRT	D014581	Urticaria	DISEASE	may_treat	phenyltoloxamine citrate
MEDRT	D014581	Urticaria	DISEASE	may_treat	phenyltoloxamine
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	phenyltoloxamine citrate
MEDRT	N0000000190	Histamine H1 Receptor Antagonists	MOA	has_moa	phenyltoloxamine
MEDRT	N0000175439	Analgesia	PE	has_pe	phenyltoloxamine citrate
MEDRT	N0000175439	Analgesia	PE	has_pe	phenyltoloxamine
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	phenyltoloxamine citrate
MEDRT	N0000008657	Decreased Histamine Activity	PE	has_pe	phenyltoloxamine

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Oral Solution	rxnav_allrelated
DFG	DFG	Oral Liquid Product	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
IN	IN	phenyltoloxamine	rxnav_allrelated
MIN	MIN	chlorpheniramine / phenylephrine / phenyltoloxamine	rxnav_allrelated
PIN	PIN	phenyltoloxamine citrate	rxnav_allrelated
SCD	SCD	chlorpheniramine maleate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenyltoloxamine citrate 1.5 MG/ML Oral Solution	rxnav_allrelated
SCDC	SCDC	phenyltoloxamine citrate 1.5 MG/ML	rxnav_allrelated
SCDF	SCDF	chlorpheniramine / phenylephrine / phenyltoloxamine Oral Solution	rxnav_allrelated
SCDFP	SCDFP	chlorpheniramine maleate / phenylephrine hydrochloride / phenyltoloxamine citrate Oral Solution	rxnav_allrelated
SCDG	SCDG	chlorpheniramine / phenylephrine / phenyltoloxamine Oral Liquid Product	rxnav_allrelated
SCDG	SCDG	chlorpheniramine / phenylephrine / phenyltoloxamine Oral Product	rxnav_allrelated
SCDGP	SCDGP	chlorpheniramine maleate / phenylephrine hydrochloride / phenyltoloxamine citrate Oral Liquid Product	rxnav_allrelated
SCDGP	SCDGP	chlorpheniramine maleate / phenylephrine hydrochloride / phenyltoloxamine citrate Oral Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	GENERAL_CARDINALITY	HYBRID
ATTRIBUTES	IN_EXPRESSED_FLAG	P
ATTRIBUTES	STRENGTH	1.5 MG/ML
ATTRIBUTES	TTY	SCDC
CODES	RxCUI	1308441
NAMES	RXNAV_STR	phenyltoloxamine citrate 1.5 MG/ML
NAMES	RxNorm Name	phenyltoloxamine citrate 1.5 MG/ML